Prism Medico Pharmacy Ltd vs Visaman Global Sales Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 34.99 as of 26 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd is 0 as of March 2025 .The P/E Ratio of Visaman Global Sales Ltd is 23.2 as of March 2025 . The Market Cap of Prism Medico & Pharmacy Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Visaman Global Sales Ltd is ₹ 49.72 crore as of March 2025 . The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The revenue of Visaman Global Sales Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The ebitda of Visaman Global Sales Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The net profit of Visaman Global Sales Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Visaman Global Sales Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Visaman Global Sales Ltd

Visaman Global Sales Limited was originally incorporated on June 27, 2019 with the Registrar of Companies, Central Registration Centre.
The Company is engaged in the business of supply of round pipes, square pipes, rectangle pipes, various specification of structural steels, BGL coils, GP(GI) coils, HR coils, CR coils, colour coated coils, MS sheets, GP and GC sheets, CR sheets, HR sheets and plates, colour coated sheets, roofing PUF panel, wall PUF panel etc.
Further, it also provide the credit facility to the existing customers as value added service.
It outsource the process of modification and alteration to the third party.
Additionally, it facilitate onsite delivery of products to the customers.

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Visaman Global Sales Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 47 Cr while Market cap of Visaman Global Sales Ltd is 40 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd?

As of October 26, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹34.99. On the other hand, Visaman Global Sales Ltd stock price is INR ₹20.0.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Visaman Global Sales Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.